Co-Diagnostics, Inc. - Common Stock (CODX)

Historical Holders from Q3 2017 to Q3 2025

Symbol
CODX on Nasdaq
Type / Class
Equity / Common Stock
Shares outstanding
38,539,454
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
5,618,977
Holdings value
$1,933,651
% of all portfolios
0%
Number of holders
33
Number of buys
12
Number of sells
-12
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Co-Diagnostics, Inc. - Common Stock (CODX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Ayrton Capital LLC 9.7% $1,285,984 3,738,327 Ayrton Capital LLC 30 Sep 2025
Orca Capital AG 3.7% -18% $818,338 +$19,827 2,248,182 +2.5% Orca Capital AG 28 Oct 2025
VANGUARD GROUP INC 3.54% $620,967 1,705,952 The Vanguard Group 30 Sep 2025

Institutional Holders of Co-Diagnostics, Inc. - Common Stock (CODX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 5,618,977 $1,933,651 +$165,976 $0.344 33
2025 Q2 5,152,077 $1,441,316 -$212,861 $0.2802 35
2025 Q1 5,842,772 $1,809,752 -$47,791 $0.3096 37
2024 Q4 5,722,486 $4,291,263 +$966,445 $0.75 37
2024 Q3 4,413,670 $5,518,477 -$287,379 $1.25 35
2024 Q2 4,643,146 $5,806,110 +$363,711 $1.25 43
2024 Q1 4,360,457 $4,889,752 -$427,416 $1.12 37
2023 Q4 4,685,811 $6,249,057 +$215,592 $1.33 45
2023 Q3 4,558,729 $4,832,638 +$75,558 $1.06 44
2023 Q2 4,437,971 $4,927,496 -$1,192,291 $1.11 43
2023 Q1 5,434,763 $8,061,381 -$1,162,129 $1.48 51
2022 Q4 5,880,012 $14,841,550 -$1,029,026 $2.52 56
2022 Q3 6,212,262 $19,946,878 -$6,346,117 $3.21 59
2022 Q2 7,295,353 $40,942,337 +$3,826,530 $5.61 68
2022 Q1 6,883,296 $42,534,405 -$2,659,544 $6.18 77
2021 Q4 7,133,826 $63,708,145 -$8,131,775 $8.93 75
2021 Q3 7,988,285 $77,629,550 +$9,678,192 $9.73 75
2021 Q2 7,203,558 $59,451,608 -$18,494,228 $8.25 80
2021 Q1 9,000,777 $85,819,668 +$12,397,921 $9.54 90
2020 Q4 7,740,579 $72,035,268 +$258,006 $9.3 81
2020 Q3 7,660,605 $104,171,527 +$11,575,093 $13.59 79
2020 Q2 6,679,955 $129,181,455 +$89,131,352 $19.35 83
2020 Q1 2,132,209 $16,247,001 +$10,112,157 $7.62 44
2019 Q4 919,987 $823,000 +$42,211 $0.8945 8
2019 Q3 868,039 $894,000 +$3,123 $1.03 8
2019 Q2 947,975 $774,000 -$699,477 $0.8062 10
2019 Q1 1,808,586 $1,917,000 +$1,669,773 $1.06 9
2018 Q4 223,175 $327,000 -$22,384 $1.46 6
2018 Q3 237,905 $625,000 +$75,673 $2.63 5
2018 Q2 209,109 $811,000 +$238,187 $3.88 6
2018 Q1 155,396 $340,000 -$49,788 $2.2 7
2017 Q4 164,673 $448,000 +$49,761 $2.72 6
2017 Q3 146,972 $919,000 +$919,000 $6.29 4